YorkTest Laboratories Limited has been acquired by Ingemino Ltd.
YorkTest Laboratories Limited (YorkTest), Europe’s leading food intolerance (delayed food allergy) testing company, has been acquired by Ingemino Ltd., a newly established company formed by successful entrepreneurs Keith Tozzi and Fiona Begley. Financial details will remain confidential.
YorkTest manufactures and markets a number of self-test services of laboratory analyzed diagnostic home health tests direct to consumers, to medical laboratories and to practitioners both in the UK and in over 50 countries around the world. The company’s aim is to empower people with informed, personal insights to enable them to change their diet and improve their health. Combined with increasing media coverage and powerful endorsements from key opinion leaders, including world renowned marathon runner Paula Ratcliffe, YorkTest has seen sustained profitable growth over the past few years. Tom Hardman, YorkTest’s Managing Director, will join the board of Ingemino.
Ingemino Ltd. is a newly formed company that has been established to acquire, develop and grow a series of key businesses in the testing arena. The focus of the business is laboratory-based testing solutions and the key objective is to develop Ingemino into a world-class organization through a combination of complementary acquisitions and aggressive organic growth. The acquisition was supported by Close Brothers Private Equity (CPBE Capital).
Oaklins Cavendish, based in the UK, advised the seller in this transaction.
Talk to the deal team
Lord Leigh of Hurley
Oaklins Cavendish
Related deals
Triscan has joined APA and Riverarch to accelerate growth in the European aftermarket
Triscan AS, a leading provider of OE-quality automotive spare parts for the professional aftermarket in Europe, has been acquired by APA Industries, LLC, a portfolio company of Riverarch Equity Partners.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn more